"Life Sciences Litigation"

Life Sciences Litigation

CRA’s life sciences litigation support is grounded in a comprehensive understanding of pharmaceutical, biotechnology, medical device, and diagnostic markets. For more than 30 years, our experts have consulted with major life science companies, law firms, and regulatory agencies around the globe, providing the industry experience and analytical expertise needed to solve their most challenging strategic problems and resolve their most contentious disputes.

CRA has a reputation for delivering rigorous analysis and expert testimony that meets the highest standards. Our witnesses are respected for their professional excellence and effectiveness in highly demanding life sciences cases. Our team members have extensive business consulting and litigation experience in the life sciences industries. The academic backgrounds of our consultants are complemented by results-focused, practical experience. This combination allows CRA to apply effective expert testimony and non-testifying expertise to our clients’ most important problems.

Client challenges


Regulatory agency proceedings


  • Antitrust
  • Commercial disputes
  • Intellectual property
  • Government investigations
  • Canadian Ministry of Health
  • US Federal Trade Commission
  • European Commission
  • UK Office of Fair Trading

Disputes involving

  • Antitrust, including reverse payments and delayed generic entry
  • Class certification
  • Commercially reasonable efforts
  • Damages assessment
  • Economic fraud
  • Government investigations
  • Intellectual property disputes and valuations
  • International arbitrations
  • Off-label marketing and product liability
  • Pricing, reimbursement, and distribution
  • Transfer pricing policy
  • Labor and employment


Lori Possel
United States

Stacey Cornell
United Kingdom